curasan AG (CUR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:curasan AG (CUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7069
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, oral and maxillofacial surgeons, and periodontists and dental implantologists in the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company has a research and development, and manufacturing facility in Frankfurt, Germany. The company offers its products through a network of distributors in the Americas, Europe, the Middle East and Asia. curasan is headquartered in Kleinostheim, Germany.

curasan AG (CUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
curasan AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
curasan AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
curasan AG, Medical Equipment, Deal Details 10
Partnerships 10
Xtant Medical Enters into Distribution Agreement with Curasan 10
curasan Enters into Licensing Agreement with Silony Medical 11
Equity Offering 12
Curasan Raises USD2.7 Million in Second Tranche of Rights offering of Shares 12
Curasan to Raise USD6 Million in Private Placement of Shares 13
Curasan to Raise Funds through Private Placement of Shares 14
Curasan Raises USD1.2 Million in Private Placement of Shares 15
curasan to Raise USD4.6 Million in Rights Issue of Shares 16
curasan AG – Key Competitors 17
curasan AG – Key Employees 18
curasan AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 24, 2018: curasan concludes first quarter in line with annual guidance 20
Apr 26, 2018: Curasan Reports Full Year 2017 Financial Results 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
curasan AG, Medical Equipment, Key Facts, 2017 2
curasan AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
curasan AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
curasan AG, Deals By Market, 2012 to YTD 2018 8
curasan AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Xtant Medical Enters into Distribution Agreement with Curasan 10
curasan Enters into Licensing Agreement with Silony Medical 11
Curasan Raises USD2.7 Million in Second Tranche of Rights offering of Shares 12
Curasan to Raise USD6 Million in Private Placement of Shares 13
Curasan to Raise Funds through Private Placement of Shares 14
Curasan Raises USD1.2 Million in Private Placement of Shares 15
curasan to Raise USD4.6 Million in Rights Issue of Shares 16
curasan AG, Key Competitors 17
curasan AG, Key Employees 18
curasan AG, Subsidiaries 19

List of Figures
curasan AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
curasan AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
curasan AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
curasan AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[curasan AG (CUR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • Mirabilis Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Mirabilis Medical Inc (Mirabilis Medical) is a healthcare equipment company that develops a non-invasive therapeutic ultrasound platform for the treatment of uterine fibroids in women. The company offers platform that targets symptoms of uterine fibroids such as pain, abnormal bleeding, preg …
  • Decmil Group Ltd (DCG):企業の財務・戦略的SWOT分析
    Summary Decmil Group Ltd (Decmil), is a provider of construction, engineering and accommodation and project management services. The company provides services such as design, accommodation services, civil engineering, construction, and maintenance services, among others. Decmil provides government i …
  • National Research Council of Canada:企業のM&A・事業提携・投資動向
    National Research Council of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Research Council of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Quadrise Fuels International Plc (QFI):石油・ガス:M&Aディール及び事業提携情報
    Summary Quadrise Fuels International Plc (QFI), previously Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multi phase Superfine Atomized Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation …
  • Entek Energy Ltd (ETE):石油・ガス:M&Aディール及び事業提携情報
    Summary Entek Energy Limited (Entek Energy) is an upstream energy company that carries out the exploration, production and development of oil and gas reserves in addition to investment in the energy resources industry. It acquires oil and gas assets and explores conventional and unconventional sourc …
  • Veloxis Pharmaceuticals AS:企業の戦略的SWOT分析
    Veloxis Pharmaceuticals AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Gentex Corporation:企業の戦略・SWOT・財務情報
    Gentex Corporation - Strategy, SWOT and Corporate Finance Report Summary Gentex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Semiconductor Manufacturing International Corp (981):企業の財務・戦略的SWOT分析
    Summary Semiconductor Manufacturing International Corp (SMIC) is a semiconductor foundry manufacturer that offers integrated circuit foundry and technology services. The company provides complete foundry solutions with services that include mask services, backend design services, IP development, and …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • City Utilities of Springfield:企業の戦略的SWOT分析
    City Utilities of Springfield - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務情報
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PTT Public Co Ltd (PTT)-石油・ガス分野:企業M&A・提携分析
    Summary PTT Public Company Limited (PTT) is an integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, tr …
  • MDF Instruments Direct Inc:企業の戦略的SWOT分析
    MDF Instruments Direct Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Marr S.P.A.
    Marr S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Marr S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Penumbra Inc (PEN):医療機器:M&Aディール及び事業提携情報
    Summary Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures and markets neuro devices and peripheral devices. The company’s neurovascular mechanical thrombectomy systems include revascularization device, reperfusion catheters, distal delivery catheters, neuro eva …
  • Northfork Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Northfork Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆